BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3223380)

  • 1. MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
    Sacchi A; Falcioni R; Tibursi G; Apollonj Ghetti C
    Adv Exp Med Biol; 1988; 233():141-50. PubMed ID: 3223380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.
    Sacchi A; Piaggio G; Rizzo MA; Falcioni R; Kennel SJ
    Clin Exp Metastasis; 1989; 7(1):41-54. PubMed ID: 2783240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype.
    Sacchi A; Falcioni R; Piaggio G; Gianfelice MA; Perrotti N; Kennel SJ
    Cancer Res; 1989 May; 49(10):2615-20. PubMed ID: 2713845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen.
    Sacchi A; Kennel S; Natali PG; Tibursi G; Ghetti CA
    Clin Exp Metastasis; 1987 Sep; 5(3):245-57. PubMed ID: 3652554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic phenotype: growth factor dependence and integrin expression.
    Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
    Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
    Isakov N; Feldman M; Segal S
    Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line.
    Inokuchi J; Jimbo M; Kumamoto Y; Shimeno H; Nagamatsu A
    Clin Exp Metastasis; 1993 Jan; 11(1):27-36. PubMed ID: 8422703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.
    Plaksin D; Gelber C; Feldman M; Eisenbach L
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4463-7. PubMed ID: 3380801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between transcriptional products and cell surface expression of MHC class I antigens in metastatic and non-metastatic Lewis lung tumor cells.
    Juul-Madsen HR; Olsson L
    APMIS; 1990 Jul; 98(7):624-36. PubMed ID: 1697757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties.
    Isakov N; Katzav S; Feldman M; Segal S
    J Natl Cancer Inst; 1983 Jul; 71(1):139-45. PubMed ID: 6345878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue.
    Falcioni R; Sacchi A; Resau J; Kennel SJ
    Cancer Res; 1988 Feb; 48(4):816-21. PubMed ID: 2448027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
    Ashley MP; Kotlarski I
    Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():323-8. PubMed ID: 3679289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance of MHC class I expression in 3LL tumour cells.
    Benihoud K; Lecerf JM; Bobé P; Kiger N
    Eur J Immunogenet; 1991; 18(5-6):355-65. PubMed ID: 1772880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
    Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
    Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced phosphorylation of the beta-4 integrin subunit expressed on murine metastatic carcinoma cells.
    Falcioni R; Perrotti N; Piaggio G; Kennel SK; Sacchi A
    Mol Carcinog; 1989; 2(6):361-8. PubMed ID: 2695104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a surface antigen, common to murine lung and Lewis lung carcinoma, by monoclonal antibody.
    Hadas E; Hurwitz E; Eshhar Z
    Int J Cancer; 1984 Mar; 33(3):369-74. PubMed ID: 6365802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
    Yamit-Hezi A; Plaksin D; Eisenbach L
    Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in surface antigen of cell lines and clones from a murine carcinoma.
    Kiger N
    Int J Cancer; 1985 Jan; 35(1):129-34. PubMed ID: 3881361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.